CPRX NASDAQ
Catalyst Pharmaceuticals, Inc.
1W: +0.0%
1M: +0.3%
3M: +20.8%
YTD: +36.0%
1Y: +49.7%
3Y: +144.9%
5Y: +472.6%
$31.49
Last traded 2026-07-21 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$597M
Revenue
+11.7% YoY
$221M
Net Income
+12.1% YoY
$208M
Free Cash Flow
-22.2% YoY
83.8%
Gross Margin
49.0%
Op. Margin
42.7%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE24.5%
ROA21.5%
ROIC77.0%
Valuation
P/E17.5
P/B3.8
EV/EBITDA7.1
Leverage
Debt/Equity0.00
Current Ratio7.10
Interest Cov.0.0x
Quality Scores
Piotroski F5/9
Altman Z16.83
Beneish M-1.73